Taking into account that CCL20 expression can also be upregulated in other organs under inflammatory conditions (80, 81) it cannot be completely excluded that CCR6+ ILC2s might partly also migrate to other CF-affected organs besides the lung. This evidence concerns the gene CCL20 and cystic fibrosis.